Virginia Commonwealth University
How are you Testing your NASH Patients?
Why risk-stratification in NASH patients is so important
Medscape Education Diabetes & Endocrinology
Implementing Best Practices in Fatty Liver Disease
In this Medscape activity, Dr. Cusi summarizes key points on the diagnosis and treatment strategies of NAFLD
University Medical Center Mainz, Germany
Redefining the NAFLD/NASH Referral Pathway: A Hepatologist's Perspective
Utility of noninvasive tests such as the ELF Test in the patient referral pathway
Virgen del Rocío University Hospital; SeLiver group at Institute of Biomedicie of Seville (IBIS), University of Seville, Sevilla, Spain
Multidisciplinary Approach in the NAFLD/NASH Patient Care Pathway
An understanding of NAFLD/NASH across specialties and why the use of noninvasive tests are needed.
Atlanta Endocrine Associates, Atlanta, Georgia
NASH Prevalence in Type 2 Diabetes Patients and Use of Noninvasive Tests
How do endocrinologists manage type 2 diabetes patients with NAFLD/NASH?
University of Angers, Angers, France
Noninvasive Liver Fibrosis Testing Starts in the Primary Care Setting
Turning the tide against nonalcoholic fatty liver disease (NAFLD)
Cedars Sinai, Los Angeles, CA
Noninvasive Prognostic Tests in NASH Patient Management
How noninvasive tests such as the ELF™ Test are changing the field.
The U.S. Economic Burden of Nonalcoholic Steatohepatitis (NASH)
Noninvasive tests provide an important tool to help reduce healthcare costs.
MedTech Europe, produced by BBC Story Works: Connecting the Dots video series
NAFLD Patient Pathway Story
Hear from a NAFLD patient about his journey along with the clinical experts who helped develop the pathway
Non-invasive tests can help reduce unnecessary referrals in patients with NAFLD
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.